-
1دورية أكاديمية
المؤلفون: Wong YN; Fox Chase Cancer Center, Philadelphia, PA. Electronic address: yuningwong123@gmail.com., Manola J; Dana-Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, MA., Hudes GR; Fox Chase Cancer Center, Philadelphia, PA., Roth BJ; Indiana University, Indianapolis, IN., Moul JW; Walter Reed Army Medical Center, Washington, DC., Barsevick AM; Fox Chase Cancer Center, Philadelphia, PA., Scher RM; Fox Chase Cancer Center, Philadelphia, PA., Volk MJ; Saint Vincent Hospital, Green Bay, WI., Vaughn DJ; University of Pennsylvania, Philadelphia, PA., Williams SD; Indiana University, Indianapolis, IN., Fisch MJ; University of Virginia, Charlottesville, VA., Cella D; Evanston Hospital, Evanston, IL., Carducci MA; Johns Hopkins University, Baltimore, MD., Wilding G; University of Wisconsin Carbone Cancer Center, Madison, WI.
المصدر: Clinical genitourinary cancer [Clin Genitourin Cancer] 2018 Apr; Vol. 16 (2), pp. e315-e322. Date of Electronic Publication: 2017 Oct 16.
نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Estramustine/*administration & dosage , Paclitaxel/*administration & dosage , Prostatic Neoplasms, Castration-Resistant/*drug therapy, Administration, Intravenous ; Administration, Oral ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Drug Administration Schedule ; Estramustine/adverse effects ; Humans ; Male ; Middle Aged ; Paclitaxel/adverse effects ; Prostate-Specific Antigen/metabolism ; Prostatic Neoplasms, Castration-Resistant/metabolism ; Survival Analysis ; Treatment Outcome
-
2دورية أكاديمية
المؤلفون: DiPaola RS; Department of Medicine, The Cancer Institute of New Jersey, UMDNJ-RWJMS, New Brunswick NJ, USA. dipaolrs@umdnj.edu, Chen YH, Stein M, Vaughn D, Patrick-Miller L, Carducci M, Roth B, White E, Wilding G
المصدر: Journal of translational medicine [J Transl Med] 2010 Feb 24; Vol. 8, pp. 20. Date of Electronic Publication: 2010 Feb 24.
نوع المنشور: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE
مواضيع طبية MeSH: Prostatic Neoplasms*/drug therapy , Prostatic Neoplasms*/mortality , Prostatic Neoplasms*/pathology, Antineoplastic Agents/*therapeutic use , Estramustine/*therapeutic use , Interferons/*therapeutic use , Isotretinoin/*therapeutic use , Mitoxantrone/*therapeutic use , Paclitaxel/*therapeutic use , Proto-Oncogene Proteins c-bcl-2/*metabolism , Vinblastine/*analogs & derivatives, Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Quality of Life ; Survival Rate ; Teratogens ; Treatment Outcome ; Vinblastine/therapeutic use ; Vinorelbine
-
3دورية أكاديمية
المؤلفون: Liu G; University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison, Wisconsin 53792, USA. gxl@medicine.wisc.edu, Kolesar J, McNeel DG, Leith C, Schell K, Eickhoff J, Lee F, Traynor A, Marnocha R, Alberti D, Zwiebel J, Wilding G
المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2008 May 01; Vol. 14 (9), pp. 2732-9.
نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Print ISSN: 1078-0432 (Print) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Carboplatin/*therapeutic use , Neoplasms/*drug therapy , Oligonucleotides, Antisense/*therapeutic use , Paclitaxel/*therapeutic use , Thionucleotides/*therapeutic use, Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics ; Carboplatin/administration & dosage ; Carboplatin/pharmacokinetics ; Combined Modality Therapy ; Down-Regulation ; Female ; Gene Expression ; Genes, bcl-2 ; Humans ; Male ; Neoplasms/genetics ; Neoplasms/metabolism ; Oligonucleotides, Antisense/pharmacokinetics ; Paclitaxel/administration & dosage ; Paclitaxel/pharmacokinetics ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Thionucleotides/administration & dosage ; Thionucleotides/adverse effects ; Thionucleotides/pharmacokinetics ; bcl-2-Associated X Protein/metabolism
-
4دورية أكاديمية
المؤلفون: Bailey HH; University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison, Wisconsin 53792, USA. hhbailey@wisc.edu, Alberti DB, Thomas JP, Mulkerin DL, Binger KA, Gottardis MM, Martell RE, Wilding G
المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2007 Jun 15; Vol. 13 (12), pp. 3623-9. Date of Electronic Publication: 2007 May 17.
نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural
بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1078-0432 (Print) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Benzodiazepines/*administration & dosage , Imidazoles/*administration & dosage , Neoplasms/*drug therapy , Paclitaxel/*administration & dosage, Adult ; Aged ; Benzodiazepines/adverse effects ; Benzodiazepines/pharmacokinetics ; Female ; Humans ; Imidazoles/adverse effects ; Imidazoles/pharmacokinetics ; Male ; Maximum Tolerated Dose ; Middle Aged ; Paclitaxel/adverse effects ; Paclitaxel/pharmacokinetics
-
5دورية أكاديمية
المؤلفون: Liu G; University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, USA., Bailey HH, Arzoomanian RZ, Alberti D, Binger K, Volkman J, Feierabend C, Marnocha R, Wilding G, Thomas JP
المصدر: American journal of clinical oncology [Am J Clin Oncol] 2003 Jun; Vol. 26 (3), pp. 280-4.
نوع المنشور: Clinical Trial; Clinical Trial, Phase I; Journal Article
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8207754 Publication Model: Print Cited Medium: Internet ISSN: 1537-453X (Electronic) Linking ISSN: 02773732 NLM ISO Abbreviation: Am J Clin Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Deoxycytidine/*administration & dosage , Deoxycytidine/*analogs & derivatives , Paclitaxel/*administration & dosage , Pyrimidines/*administration & dosage, Adult ; Aged ; Aged, 80 and over ; Antimetabolites, Antineoplastic/administration & dosage ; Female ; Folic Acid Antagonists/administration & dosage ; Humans ; Male ; Maximum Tolerated Dose ; Middle Aged ; Gemcitabine
-
6دورية أكاديمية
المؤلفون: Dreicer R; Department of Hematology/Oncology and the Urologic Institute, Cleveland Clinic Foundation, Ohio 44195, USA. dreicer@cc.ccf.org, Manola J, Schneider DJ, Schwerkoske JF, George CS, Roth BJ, Wilding G
مؤلفون مشاركون: Eastern Cooperative Oncology Group
المصدر: Cancer [Cancer] 2003 Jun 01; Vol. 97 (11), pp. 2743-7.
نوع المنشور: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Print ISSN: 0008-543X (Print) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Taxoids*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Carcinoma, Transitional Cell/*drug therapy , Deoxycytidine/*analogs & derivatives , Paclitaxel/*analogs & derivatives , Urologic Neoplasms/*drug therapy, Aged ; Antimetabolites, Antineoplastic/administration & dosage ; Antimetabolites, Antineoplastic/adverse effects ; Antineoplastic Agents, Phytogenic/administration & dosage ; Antineoplastic Agents, Phytogenic/adverse effects ; Deoxycytidine/administration & dosage ; Deoxycytidine/adverse effects ; Docetaxel ; Drug Administration Schedule ; Female ; Humans ; Male ; Middle Aged ; Paclitaxel/administration & dosage ; Paclitaxel/adverse effects ; Urothelium ; Gemcitabine
-
7دورية أكاديمية
المؤلفون: Dreicer R; Departments of Hematology/Oncology and Urology, The Cleveland Clinic Foundation, Cleveland, OH, USA. dreicer@ccf.org, Manola J, Roth BJ, Cohen MB, Hatfield AK, Wilding G
المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2000 Mar; Vol. 18 (5), pp. 1058-61.
نوع المنشور: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S.
بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Print ISSN: 0732-183X (Print) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Carcinoma, Transitional Cell/*drug therapy , Cisplatin/*therapeutic use , Paclitaxel/*therapeutic use , Urologic Neoplasms/*drug therapy, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cisplatin/administration & dosage ; Cisplatin/adverse effects ; Female ; Humans ; Male ; Middle Aged ; Paclitaxel/administration & dosage ; Paclitaxel/adverse effects ; Treatment Outcome ; Urothelium
-
8دورية أكاديمية
المؤلفون: Roth BJ; Indiana University Medical Center, Indianapolis., Yeap BY, Wilding G, Kasimis B, McLeod D, Loehrer PJ
المصدر: Cancer [Cancer] 1993 Oct 15; Vol. 72 (8), pp. 2457-60.
نوع المنشور: Case Reports; Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S.
بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Print ISSN: 0008-543X (Print) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Paclitaxel/*therapeutic use , Prostatic Neoplasms/*drug therapy, Aged ; Death, Sudden, Cardiac/etiology ; Drug Resistance ; Estrogens/therapeutic use ; Gonadotropin-Releasing Hormone/therapeutic use ; Humans ; Leukopenia/chemically induced ; Male ; Middle Aged ; Myocardial Infarction/chemically induced ; Paclitaxel/adverse effects ; Prostatic Neoplasms/mortality ; Survival Rate
-
9دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
10دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.